Real-time enrollment status for this chickenpox clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:52 PM UTC
| NCT Number | NCT06855160 |
| Recruiting Status | Recruiting |
| Condition | Chickenpox |
| Phase | PHASE3 |
| Target Enrollment | 911 participants |
| Active Locations | 13 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 17, 2026: Clinical trial NCT06855160 is currently recruiting participants. This phase3 study for chickenpox is actively seeking new participants at 13 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06855160 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06855160 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.